Related Experiment Video
Updated: Apr 17, 2026

Author Spotlight: Regenerative Peripheral Nerve Interface (RPNI) Surgery in Postamputation Pain Management
Published on: March 15, 2024
Peripheral neuropathy associated with ipilimumab: a report of 2 cases
Iyavut Thaipisuttikul1, Paul Chapman, Edward K Avila
1Departments of *Neurology †Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract:
Ipilimumab, a monoclonal antibody targeting human cytotoxic T-lymphocyte-associated antigen 4, was approved by the FDA and European Medicines Agency for the treatment of metastatic melanoma. Immune-related adverse effects can occur with the use of this agent, but peripheral nervous system problems are rare. We report 2 cases of ipilimumab-induced polyneuropathy.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Neuropathy
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Peripheral Artery Disease III: Interprofessional Care

